minoxidil has been researched along with Tachycardia in 17 studies
Minoxidil: A potent direct-acting peripheral vasodilator (VASODILATOR AGENTS) that reduces peripheral resistance and produces a fall in BLOOD PRESSURE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p371)
minoxidil : A pyrimidine N-oxide that is pyrimidine-2,4-diamine 3-oxide substituted by a piperidin-1-yl group at position 6.
Tachycardia: Abnormally rapid heartbeat, usually with a HEART RATE above 100 beats per minute for adults. Tachycardia accompanied by disturbance in the cardiac depolarization (cardiac arrhythmia) is called tachyarrhythmia.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effect of the new vasodilator, minoxidil, on blood pressure and plasma renin activity was studied in 21 hypertensive patients: 12 patients with essential and 9 with renal hypertension." | 9.04 | The effect of minoxidil on blood pressure and plasma renin activity in patients with essential and renal hypertension. ( Werning, C, 1976) |
| "The effects of minoxidil on the electrocardiogram (EKG) were assessed in a prospective investigation of 112 patients with severe hypertension during an observation period representing 241." | 7.66 | Serial electrocardiographic changes during long-term treatment of severe hypertension with minoxidil. ( Froer, KL; Hall, D; Rudolph, W, 1980) |
| "Minoxidil is a potent antihypertensive drug widely used in severe arterial hypertension and in that refractory to treatment." | 7.66 | Minoxidil in severe and moderately severe hypertension, in association with methyldopa and chlortalidone. ( Cotorruelo, JG; Flórez, J; Llamazares, C, 1982) |
| " Propranolol and furosemide were administered concomitantly to control reflex tachycardia and fluid retention." | 7.65 | The outpatient treatment of refractory hypertension with minoxidil. ( Ball, JH; Kleiner, JP; Nelson, WP; Norton, JD, 1977) |
| " Propranolol and diuretics were given to prevent reflex tachycardia and fluid retention." | 7.65 | Severe hypertension. Treatment with minoxidil. ( Dunea, G; Mahurkar, SD; Mamdani, B; Mehta, PK; Shansky, RM, 1975) |
| "Propranolol was demonstrated to block hydralazine-induced increases in serum renin activity in genetically hypertensive rats." | 5.25 | Altered renin release and propranolol potentiation of vasodilatory drug hypotension. ( Keeton, K; Pettinger, WA, 1975) |
| "The effect of the new vasodilator, minoxidil, on blood pressure and plasma renin activity was studied in 21 hypertensive patients: 12 patients with essential and 9 with renal hypertension." | 5.04 | The effect of minoxidil on blood pressure and plasma renin activity in patients with essential and renal hypertension. ( Werning, C, 1976) |
| "The effects of minoxidil on the electrocardiogram (EKG) were assessed in a prospective investigation of 112 patients with severe hypertension during an observation period representing 241." | 3.66 | Serial electrocardiographic changes during long-term treatment of severe hypertension with minoxidil. ( Froer, KL; Hall, D; Rudolph, W, 1980) |
| "Minoxidil is a potent antihypertensive drug widely used in severe arterial hypertension and in that refractory to treatment." | 3.66 | Minoxidil in severe and moderately severe hypertension, in association with methyldopa and chlortalidone. ( Cotorruelo, JG; Flórez, J; Llamazares, C, 1982) |
| " Propranolol and furosemide were administered concomitantly to control reflex tachycardia and fluid retention." | 3.65 | The outpatient treatment of refractory hypertension with minoxidil. ( Ball, JH; Kleiner, JP; Nelson, WP; Norton, JD, 1977) |
| " Propranolol and diuretics were given to prevent reflex tachycardia and fluid retention." | 3.65 | Severe hypertension. Treatment with minoxidil. ( Dunea, G; Mahurkar, SD; Mamdani, B; Mehta, PK; Shansky, RM, 1975) |
| "The major concern regarding the use of low-dose oral minoxidil (LDOM) for the treatment of hair loss is the potential risk of systemic adverse effects." | 1.62 | Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients. ( Bhoyrul, B; Hermosa-Gelbard, A; Jaén-Olasolo, P; Jerjen, R; Jimenez-Cauhe, J; John, JM; Koh, WL; Lo-Sicco, K; Moreno-Arrones, ÓM; Piraccini, BM; Pirmez, R; Poa, JE; Rodrigues-Barata, R; Rudnicka, L; Saceda-Corralo, D; Salas-Callo, CI; Shapiro, J; Sinclair, R; Starace, M; Tosti, A; Trindade de Carvalho, L; Vañó-Galván, S; Vincenzi, C; Waskiel-Burnat, A; Yin, L; Zamorano, JL, 2021) |
| "Minoxidil is a strong vasodilator used first in the 1970s for severe hypertension." | 1.37 | [Minoxidil intoxication, the pharmacological agent of a hair lotion]. ( Aprahamian, A; Chéron, G; Escoda, S; Merckx, A; Patteau, G, 2011) |
| "Minoxidil-treated pigs had tachycardia and hypotension and were killed 24 hr after the second dose." | 1.27 | Cardiac morphologic alterations in acute minoxidil cardiotoxicity in miniature swine. ( Ferrans, VJ; Herman, EH; Van Vleet, JF, 1984) |
| "Propranolol was demonstrated to block hydralazine-induced increases in serum renin activity in genetically hypertensive rats." | 1.25 | Altered renin release and propranolol potentiation of vasodilatory drug hypotension. ( Keeton, K; Pettinger, WA, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (64.71) | 18.7374 |
| 1990's | 1 (5.88) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (17.65) | 24.3611 |
| 2020's | 2 (11.76) | 2.80 |
| Authors | Studies |
|---|---|
| Vañó-Galván, S | 2 |
| Trindade de Carvalho, L | 2 |
| Saceda-Corralo, D | 2 |
| Rodrigues-Barata, R | 2 |
| Kerkemeyer, KL | 1 |
| Sinclair, RD | 1 |
| Hermosa-Gelbard, Á | 2 |
| Moreno-Arrones, ÓM | 2 |
| Jimenez-Cauhe, J | 2 |
| Bhoyrul, B | 2 |
| Pirmez, R | 1 |
| Koh, WL | 1 |
| Poa, JE | 1 |
| Jerjen, R | 1 |
| John, JM | 1 |
| Salas-Callo, CI | 1 |
| Vincenzi, C | 1 |
| Yin, L | 1 |
| Lo-Sicco, K | 1 |
| Waskiel-Burnat, A | 1 |
| Starace, M | 1 |
| Zamorano, JL | 1 |
| Jaén-Olasolo, P | 1 |
| Piraccini, BM | 1 |
| Rudnicka, L | 1 |
| Shapiro, J | 1 |
| Tosti, A | 1 |
| Sinclair, R | 1 |
| Jordan, TJM | 1 |
| Yaxley, PE | 1 |
| Culler, CA | 1 |
| Balakrishnan, A | 1 |
| Cohn, JN | 1 |
| McInnes, GT | 1 |
| Shepherd, AM | 1 |
| Aprahamian, A | 1 |
| Escoda, S | 1 |
| Patteau, G | 1 |
| Merckx, A | 1 |
| Chéron, G | 1 |
| Hall, D | 1 |
| Froer, KL | 1 |
| Rudolph, W | 1 |
| Van Vleet, JF | 1 |
| Herman, EH | 2 |
| Ferrans, VJ | 2 |
| Cotorruelo, JG | 1 |
| Llamazares, C | 1 |
| Flórez, J | 1 |
| Golterman-Hardenberg, JC | 1 |
| Sobota, JT | 1 |
| Martin, WB | 1 |
| Carlson, RG | 1 |
| Feenstra, ES | 1 |
| Höffler, D | 1 |
| Demers, HG | 1 |
| Pettinger, WA | 1 |
| Keeton, K | 1 |
| Balazs, T | 1 |
| Young, R | 1 |
| Earl, FL | 1 |
| Krop, S | 1 |
| Werning, C | 1 |
| Kleiner, JP | 1 |
| Ball, JH | 1 |
| Nelson, WP | 1 |
| Norton, JD | 1 |
| Mehta, PK | 1 |
| Mamdani, B | 1 |
| Shansky, RM | 1 |
| Mahurkar, SD | 1 |
| Dunea, G | 1 |
| Dogterom, P | 1 |
| Zbinden, G | 1 |
| Reznik, GK | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Randomised, Crossover Bioavailability Clinical Trial of Oral Minoxidil 1 MG, After Single and Multiple Dose Administration to Healthy Volunteers Under Fasting Conditions.[NCT06015516] | Phase 1 | 14 participants (Anticipated) | Interventional | 2024-02-29 | Not yet recruiting | ||
| International Phase III, Multi Center, Randomized, Double Blind, Placebo and Active Controlled and Parallel Group Clinical Trial to Evaluate the Efficacy and Safety of Oral Minoxidil 1 mg in Female Patients With Androgenetic Alopecia[NCT05888922] | Phase 3 | 520 participants (Anticipated) | Interventional | 2024-03-31 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for minoxidil and Tachycardia
| Article | Year |
|---|---|
Direct-acting vasodilators.
Topics: Antihypertensive Agents; Hirsutism; Humans; Hydralazine; Hypertension; Minoxidil; Tachycardia; Treat | 2011 |
Cardiotoxicity of vasodilators and positive inotropic/vasodilating drugs in dogs: an overview.
Topics: Amines; Animals; Animals, Laboratory; Coronary Disease; Dogs; Humans; Minoxidil; Myocardium; Necrosi | 1992 |
1 trial available for minoxidil and Tachycardia
| Article | Year |
|---|---|
The effect of minoxidil on blood pressure and plasma renin activity in patients with essential and renal hypertension.
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Edema; Female; Humans; Hypertension; Hyperten | 1976 |
14 other studies available for minoxidil and Tachycardia
| Article | Year |
|---|---|
Oral minoxidil improves background hair thickness in lichen planopilaris.
Topics: Administration, Oral; Adult; Aged; Alopecia; Female; Hair; Humans; Hypertrichosis; Hypotension, Orth | 2021 |
Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Alopecia; Child; Dizziness; Edema; | 2021 |
Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Alopecia; Child; Dizziness; Edema; | 2021 |
Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Alopecia; Child; Dizziness; Edema; | 2021 |
Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Alopecia; Child; Dizziness; Edema; | 2021 |
Successful management of minoxidil toxicosis in a dog.
Topics: Animals; Dog Diseases; Dogs; Dopamine; Emulsions; Heart Rate; Hypotension; Minoxidil; Phospholipids; | 2018 |
[Minoxidil intoxication, the pharmacological agent of a hair lotion].
Topics: Child, Preschool; Female; Hair Preparations; Humans; Hypotension; Minoxidil; Monitoring, Physiologic | 2011 |
Serial electrocardiographic changes during long-term treatment of severe hypertension with minoxidil.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Child; Child, Preschool; Coron | 1980 |
Cardiac morphologic alterations in acute minoxidil cardiotoxicity in miniature swine.
Topics: Animals; Arterioles; Coronary Vessels; Dogs; Endothelium; Heart Atria; Heart Diseases; Hemorrhage; H | 1984 |
Minoxidil in severe and moderately severe hypertension, in association with methyldopa and chlortalidone.
Topics: Adult; Aged; Body Water; Chlorthalidone; Creatinine; Drug Therapy, Combination; Heart Rate; Humans; | 1982 |
Experiences with the antihypertensive drug minoxidil.
Topics: Adult; Aged; Blood Pressure; Edema; Evaluation Studies as Topic; Female; Heart; Hirsutism; Humans; H | 1980 |
Minoxidil: right atrial cardiac pathology in animals and in man.
Topics: Adult; Aged; Animals; Dogs; Female; Heart Atria; Heart Failure; Humans; Hypertension; Kidney Failure | 1980 |
[Minoxidil in the treatment of malignant hypertension (author's transl)].
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Drug Therapy, Combination; Female; Humans; Hyper | 1977 |
Altered renin release and propranolol potentiation of vasodilatory drug hypotension.
Topics: Angiotensin II; Animals; Blood Pressure; Central Nervous System; Depression, Chemical; Dose-Response | 1975 |
Acute cardiomyopathy induced by the vasodilating antihypertensive agent minoxidil.
Topics: Anesthesia; Animals; Arteritis; Cardiomyopathies; Coronary Vessels; Dogs; Hemorrhage; Hypotension; M | 1979 |
The outpatient treatment of refractory hypertension with minoxidil.
Topics: Adult; Ambulatory Care; Antihypertensive Agents; Body Fluids; Colorado; Female; Furosemide; Hirsutis | 1977 |
Severe hypertension. Treatment with minoxidil.
Topics: Adult; Black People; Drug Evaluation; Edema; Female; Follow-Up Studies; Guanethidine; Humans; Hypert | 1975 |